The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

Moving one pedal at a time, a Germantown man is using his journey with cancer to inspire others to keep moving forward. And ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

This destroys the bone marrow, wiping out normal red and white blood cells (including plasma cells), and platelets, but also proportionately more (malignant) myeloma cells.

Multiple myeloma is a type of blood cancer that begins in plasma cells found in the bone marrow. About 20% of patients have a genetic change called t(4;14), which makes the NSD2 gene highly active.

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Join Drs Amelia Langston and Jonathan L. Kaufman, MD, as they discuss current CAR–T cell for B-cell lymphomas as leading researchers and practitioners in the field.

A second group of 28 multiple myeloma patients was treated with CAR T cells modified to wipe out plasma cells, which — although they are a specialized form of B cell — do not display the telltale CD19 ...